Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EORTC Groups Annual Meeting (EGAM) 2019 /
Early detection of oligometastatic disease

14th - 15th Mar 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.03.19
Views: 827

Prof Fréderic Lecouvet - Saint-Luc University, Brussels, Belgium

Prof Fréderic Lecouvet speaks to ecancer at the 2019 EORTC Groups Annual Meeting (EGAM) about the early systemic treatment of oligometastatic disease to improve patient outcomes.

Prof Lecouvet also mentions the detection of early metastatic lesions and how detection quality can vary according to the type of imaging used.

As the relationship between the early detection of oligometastatic disease and patient outcome is yet to be determined, Prof Lecouvet believes large-scale imaging trials must be conducted to investigate this.
 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation